We are excited to be offering a presentation on the new 2023 CTS COPD Guidelines!
Click here for an invitation to join us for this presentation by Dr. Erika Penz and Dr. Jeffrey Marciniuk of Saskatoon, SK.
We will offering a live viewing of the presentation on Wednesday, June 14th, at Memories Dining Room, Regina at 6:30 pm.
If interested in joining us, please RSVP Teresa Grain teresa.l.grain@gsk.com or 306-737-0961 to reserve your seat.
If you would like to attend virtually via zoom, please register below or by scanning the QR code found on the attached invitation. The link will sent to you.
https://webcastguru.zoom.us/meeting/register/tZUkcO-vpz8sHtJ4ZvWcdl2d2oGdpLlZ_OAE
Please reach out if you have any questions.
Hoping to see you at Memories or on the webinar!
Keep well,
Teresa
Teresa Grain RRT CRE
GSK General Medicines
Trelegy Anoro Incruse
Shingrix
Sr Territory Manager
Regina SK
306-737-0961
Teresa.l.grain@gsk.com
GSK surveille les courriels reçus et envoyés pour se protéger, pour protéger ses employés, clients, fournisseurs et partenaires commerciaux contre les cybermenaces et pour éviter la perte de ses données. La surveillance de GSK s’exerce selon des contrôles de confidentialité appropriés, conformément aux lois locales et à la suite d’une consultation appropriée.
If you previously subscribed to receive commercial electronic messages from GlaxoSmithKline Inc. and no longer wish to receive them, please click here to unsubscribe: http://casl.gsk.ca/ Si vous avez déjà consenti à recevoir les messages électroniques commerciaux de GlaxoSmithKline Inc. et ne souhaitez plus les recevoir, veuillez cliquer ici pour vous désabonner: http://casl.gsk.ca/fr-ca/
GSK monitors email communications sent to and from GSK in order to protect GSK, our employees, customers, suppliers and business partners, from cyber threats and loss of GSK Information. GSK monitoring is conducted with appropriate confidentiality controls and in accordance with local laws and after appropriate consultation.
